ATE309339T1 - Thrombomodulin analoga und ihre pharmazeutische verwendung - Google Patents

Thrombomodulin analoga und ihre pharmazeutische verwendung

Info

Publication number
ATE309339T1
ATE309339T1 AT01948487T AT01948487T ATE309339T1 AT E309339 T1 ATE309339 T1 AT E309339T1 AT 01948487 T AT01948487 T AT 01948487T AT 01948487 T AT01948487 T AT 01948487T AT E309339 T1 ATE309339 T1 AT E309339T1
Authority
AT
Austria
Prior art keywords
thrombomodulin
analogas
pharmaceutical use
thrombin
analogs
Prior art date
Application number
AT01948487T
Other languages
English (en)
Inventor
David Light
Michael John Morser
Mariko Nagashima
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of ATE309339T1 publication Critical patent/ATE309339T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/7455—Thrombomodulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT01948487T 2000-06-21 2001-06-20 Thrombomodulin analoga und ihre pharmazeutische verwendung ATE309339T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21367800P 2000-06-21 2000-06-21
US09/880,484 US6632791B1 (en) 2000-06-21 2001-06-12 Thrombomodulin analogs for pharmaceutical use
PCT/US2001/019590 WO2001098352A2 (en) 2000-06-21 2001-06-20 Thrombomodulin analogs for pharmaceutical use

Publications (1)

Publication Number Publication Date
ATE309339T1 true ATE309339T1 (de) 2005-11-15

Family

ID=26908302

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01948487T ATE309339T1 (de) 2000-06-21 2001-06-20 Thrombomodulin analoga und ihre pharmazeutische verwendung

Country Status (10)

Country Link
US (2) US6632791B1 (de)
EP (1) EP1292673B1 (de)
JP (1) JP4855627B2 (de)
AT (1) ATE309339T1 (de)
AU (1) AU2001269927A1 (de)
DE (1) DE60114819T2 (de)
DK (1) DK1292673T3 (de)
ES (1) ES2256266T3 (de)
NO (1) NO20026147L (de)
WO (1) WO2001098352A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030118580A1 (en) * 2001-11-09 2003-06-26 Rasmus Rojkjaer Pharmaceutical composition comprising factor VII polypeptides and thrombomodulin polypeptides
JP4460443B2 (ja) 2002-05-01 2010-05-12 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 抗凝固剤としての新規組織因子標的化された抗体
US7579000B2 (en) 2002-05-01 2009-08-25 Bayer Schering Pharma Ag Tissue factor targeted antibodies as anticoagulants
US8012693B2 (en) 2003-12-16 2011-09-06 3M Innovative Properties Company Analysis of chemically crosslinked cellular samples
US7833978B2 (en) 2004-02-20 2010-11-16 Emory University Thrombomodulin derivatives and conjugates
EP1943332A4 (de) 2005-10-14 2011-04-13 Medimmune Inc Zellpräsentation von antikörperbibliotheken
EP2120049A1 (de) 2008-05-14 2009-11-18 PAION Deutschland GmbH Lösliches Thrombomodulin als Biomarker bei Therapien mit Gerinnungshemmern
WO2010006635A1 (en) * 2008-07-16 2010-01-21 Paion Deutschland Gmbh Treatment of inflammatory bowel disease
US20110144024A1 (en) * 2008-07-16 2011-06-16 Paion Deutschland Gmbh Prevention and treatment of radiation injury
US20120165244A1 (en) * 2008-10-30 2012-06-28 Hua-Lin Wu Methods for binding lewis y antigen
JP2012529445A (ja) * 2009-06-12 2012-11-22 パイオン ドイチュラント ゲーエムベーハー 線溶亢進を伴う凝固障害の処置
CA2807749C (en) 2010-08-05 2023-02-28 Council Of Scientific & Industrial Research Protein fusion constructs possessing thrombolytic and anticoagulant properties
WO2014020183A1 (de) * 2012-08-03 2014-02-06 Ici Immunochemical Intelligence Gmbh In-vitro-assay zur diagnose von störungen der hämostase
US9156904B2 (en) * 2013-07-29 2015-10-13 Blue Blood Biotech Corp. Thrombomodulin variants and use thereof
US11085031B2 (en) * 2016-04-28 2021-08-10 Saint Louis University Thrombin-thrombomodulin fusion proteins as a powerful anticoagulant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256770A (en) 1990-04-09 1993-10-26 Schering Ag Oxidation resistant thrombomodulin analogs
US5466668A (en) 1989-04-28 1995-11-14 Schering Aktiengesellschaft Superior thrombomodulin analogs for pharmaceutical use
US6063763A (en) 1989-04-28 2000-05-16 Schering Aktiengesellschaft Protease-resistant thrombomodulin analogs
AU4533093A (en) * 1992-06-10 1994-01-04 Michael John Morser Mutants of the epidermal growth factor domains of human thrombomodulin

Also Published As

Publication number Publication date
US20030186883A1 (en) 2003-10-02
AU2001269927A1 (en) 2002-01-02
DE60114819D1 (de) 2005-12-15
US6632791B1 (en) 2003-10-14
JP4855627B2 (ja) 2012-01-18
DK1292673T3 (da) 2006-03-27
US6790828B2 (en) 2004-09-14
DE60114819T2 (de) 2006-08-10
NO20026147L (no) 2003-02-20
JP2004527452A (ja) 2004-09-09
EP1292673B1 (de) 2005-11-09
WO2001098352A3 (en) 2002-08-01
EP1292673A2 (de) 2003-03-19
NO20026147D0 (no) 2002-12-20
ES2256266T3 (es) 2006-07-16
WO2001098352A2 (en) 2001-12-27

Similar Documents

Publication Publication Date Title
ATE309339T1 (de) Thrombomodulin analoga und ihre pharmazeutische verwendung
SE0001899D0 (sv) New compounds
TR200200768T2 (tr) Yeni kuinüklidin türevleri ve bunu içeren ilaç bileşimleri
YU12103A (sh) Polimorfni oblici epotilonskog analoga
NO20055863L (no) W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
NO20034549D0 (no) Behandling av type 2 diabetes med inhibitorer av dipeptidyl peptidase IV
RS20050361A (en) Novel medicament for the treatment of chronic obstructive pulmonary diseases
ATE469136T1 (de) Inhibitoren von 11-beta- hydroxysteroiddehydrogenase typ 1
DE60333294D1 (de) Kontrollierte verabreichung von arzneien
EP1140840A4 (de) -g(v)-carboxyaryl substituierte diphenyl harnstoffe als raf kinase inhibitoren
DE50310516D1 (de) Fredericamycin-derivate
ATE291024T1 (de) Neue 4-aminofuropyrimidine und ihre verwendung
HK1068606A1 (en) Novel aminobenzoephenones
ATE282607T1 (de) Tryptase-inhibitoren
UA86399C2 (ru) Применение 2,5 дигидроксибензолсульфоновой кислоты для изготовления лекарства, которые применяют для лечения болезней, зависимых от ангиогенеза
DE59904180D1 (de) Cyclopentabenzofuran-derivate und ihre verwendung
NO975028D0 (no) Piperazinoderivater som neurokininantagonister
SE0300457D0 (sv) Novel compounds
HUP0202592A2 (hu) Lazofoxifen transzdermális adagolása
IS2849B (is) Notkun á írbesartani til framleiðslunnar á lyfjum sem eru notuð til að fyrirbyggja eða meðhöndla lungnaháþrýsting
NO20033413D0 (no) Krystallmodifisering av et syklisk depsipeptid med forbedret aktivitet
HUP0301523A2 (hu) VEGF-peptidek és alkalmazásuk angiogenezis gátlására
GB0221169D0 (en) Crystal
BR0112123A (pt) Composto
NO20020914L (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1292673

Country of ref document: EP